Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Mankind Pharma to buy 70% stake in ACTx

PRIVATEOct 15, 2026

Acquiring Company

Mankind Pharma

Acquired Company

ActX

New DelhiSeattleBiotechnologyHealth CarePharmaceuticalHealthcare

Description

Mankind Pharma has agreed to acquire a 70% stake in Belgium-based ACTx for ₹511 crore. The deal aims to enhance Mankind's portfolio in next-generation cancer therapies. This acquisition will be executed through Mankind Pharma's wholly owned subsidiary in the Netherlands. It reflects Mankind's commitment to advancing innovative treatments for cancer.

Company Information

Company

Mankind Pharma

Location

New Delhi, Delhi, India

About

Mankind Pharma is a pharmaceutical company that has completed the transaction to acquire Bharat Serums and Vaccines Ltd (BSV), for a consideration of ₹13,768 crore. This strategic move marks a significant leap for the company, positioning it as a market leader in the Indian women's health and fertility drug market alongside access to other high entry barrier products in the critical care segment with established complex R&D tech platforms.

Fundz sees it the moment Mankind Pharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Vijay
Likely contact at this company
••••••••@••••••••

See Vijay's verified email →

Divya
Likely contact at this company
••••••••@••••••••

See Divya's verified email →

Deepak
Likely contact at this company
••••••••@••••••••

See Deepak's verified email →

Rajeev
Likely contact at this company
••••••••@••••••••

See Rajeev's verified email →

Susanta
Likely contact at this company
••••••••@••••••••

See Susanta's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Mankind Pharma's next move

Learn about Strategic plan

Frequently asked

Who acquired ActX?

ActX was acquired by Mankind Pharma, based in New Delhi. The deal was reported on October 15, 2026. Mankind Pharma is a pharmaceutical company that has completed the transaction to acquire Bharat Serums and Vaccines Ltd (BSV), for a consideration of ₹13,768 crore. Mankind Pharma is privately held and operates in Biotechnology.

When did Mankind Pharma acquire ActX?

Mankind Pharma's acquisition of ActX was reported on October 15, 2026. Mankind Pharma has agreed to acquire a 70% stake in Belgium-based ACTx for ₹511 crore. The deal aims to enhance Mankind's portfolio in next-generation cancer therapies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does ActX do?

ActX, Inc. is a dynamic venture that is focused on making patient genomic information truly useful in everyday medical practice. It is privately held, operating in Healthcare, and is based in Seattle.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.